StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)

Close on Nov 18, 2026Market cap $350.75MP/E –Yield –

CorMedix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

CorMedix's price to sales ratio was 0.9× on Nov 11, 2026, against 3.6× a year earlier. Over the last 3 years it ranged from 0.9× to 478.8×, with a median of 10.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−3.4
2025Dec 31, 20254.3×−371.8
2020Apr 30, 2020376.0×+153.7
2019Oct 31, 2019222.3×−91.3
2018Jun 29, 2018313.6×–

More CorMedix figures

See a number that looks wrong?